Cargando…
Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510024/ https://www.ncbi.nlm.nih.gov/pubmed/32801131 http://dx.doi.org/10.2337/dc20-1584 |
| _version_ | 1783585706968350720 |
|---|---|
| author | Yen, Chieh-Li Wu, Chao-Yi See, Lai-Chu Li, Yi-Jung Tseng, Min-Hua Peng, Wei-Sheng Liu, Jia-Rou Chen, Yung-Chang Yen, Tzung-Hai Tian, Ya-Chung Yang, Chih-Wei Anderson, Gerard F. Yang, Huang-Yu |
| author_facet | Yen, Chieh-Li Wu, Chao-Yi See, Lai-Chu Li, Yi-Jung Tseng, Min-Hua Peng, Wei-Sheng Liu, Jia-Rou Chen, Yung-Chang Yen, Tzung-Hai Tian, Ya-Chung Yang, Chih-Wei Anderson, Gerard F. Yang, Huang-Yu |
| author_sort | Yen, Chieh-Li |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7510024 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75100242020-10-02 Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study Yen, Chieh-Li Wu, Chao-Yi See, Lai-Chu Li, Yi-Jung Tseng, Min-Hua Peng, Wei-Sheng Liu, Jia-Rou Chen, Yung-Chang Yen, Tzung-Hai Tian, Ya-Chung Yang, Chih-Wei Anderson, Gerard F. Yang, Huang-Yu Diabetes Care e-Letters: Observations American Diabetes Association 2020-10 2020-08-14 /pmc/articles/PMC7510024/ /pubmed/32801131 http://dx.doi.org/10.2337/dc20-1584 Text en © 2020 by the American Diabetes Association https://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/content/license. |
| spellingShingle | e-Letters: Observations Yen, Chieh-Li Wu, Chao-Yi See, Lai-Chu Li, Yi-Jung Tseng, Min-Hua Peng, Wei-Sheng Liu, Jia-Rou Chen, Yung-Chang Yen, Tzung-Hai Tian, Ya-Chung Yang, Chih-Wei Anderson, Gerard F. Yang, Huang-Yu Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study |
| title | Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study |
| title_full | Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study |
| title_fullStr | Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study |
| title_full_unstemmed | Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study |
| title_short | Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study |
| title_sort | pioglitazone reduces mortality and adverse events in patients with type 2 diabetes and with advanced chronic kidney disease: national cohort study |
| topic | e-Letters: Observations |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510024/ https://www.ncbi.nlm.nih.gov/pubmed/32801131 http://dx.doi.org/10.2337/dc20-1584 |
| work_keys_str_mv | AT yenchiehli pioglitazonereducesmortalityandadverseeventsinpatientswithtype2diabetesandwithadvancedchronickidneydiseasenationalcohortstudy AT wuchaoyi pioglitazonereducesmortalityandadverseeventsinpatientswithtype2diabetesandwithadvancedchronickidneydiseasenationalcohortstudy AT seelaichu pioglitazonereducesmortalityandadverseeventsinpatientswithtype2diabetesandwithadvancedchronickidneydiseasenationalcohortstudy AT liyijung pioglitazonereducesmortalityandadverseeventsinpatientswithtype2diabetesandwithadvancedchronickidneydiseasenationalcohortstudy AT tsengminhua pioglitazonereducesmortalityandadverseeventsinpatientswithtype2diabetesandwithadvancedchronickidneydiseasenationalcohortstudy AT pengweisheng pioglitazonereducesmortalityandadverseeventsinpatientswithtype2diabetesandwithadvancedchronickidneydiseasenationalcohortstudy AT liujiarou pioglitazonereducesmortalityandadverseeventsinpatientswithtype2diabetesandwithadvancedchronickidneydiseasenationalcohortstudy AT chenyungchang pioglitazonereducesmortalityandadverseeventsinpatientswithtype2diabetesandwithadvancedchronickidneydiseasenationalcohortstudy AT yentzunghai pioglitazonereducesmortalityandadverseeventsinpatientswithtype2diabetesandwithadvancedchronickidneydiseasenationalcohortstudy AT tianyachung pioglitazonereducesmortalityandadverseeventsinpatientswithtype2diabetesandwithadvancedchronickidneydiseasenationalcohortstudy AT yangchihwei pioglitazonereducesmortalityandadverseeventsinpatientswithtype2diabetesandwithadvancedchronickidneydiseasenationalcohortstudy AT andersongerardf pioglitazonereducesmortalityandadverseeventsinpatientswithtype2diabetesandwithadvancedchronickidneydiseasenationalcohortstudy AT yanghuangyu pioglitazonereducesmortalityandadverseeventsinpatientswithtype2diabetesandwithadvancedchronickidneydiseasenationalcohortstudy |